GOSS
Gossamer Bio IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$77.38M
P/E Ratio
—
EPS
$-0.71
Beta
2.16
52W High
$3.87
52W Low
$0.32
50-Day MA
$1.21
200-Day MA
$2.16
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Gossamer Bio Inc
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapies in the areas of immunology, inflammation, and oncology diseases in the United States. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $48.47M |
| Gross Profit (TTM) | $48.47M |
| EBITDA | $-163.23M |
| Operating Margin | -333.70% |
| Return on Equity | -783.00% |
| Return on Assets | -41.90% |
| Revenue/Share (TTM) | $0.21 |
| Book Value | $-0.53 |
| Price-to-Book | 2.66 |
| Price-to-Sales (TTM) | 1.60 |
| EV/Revenue | 3.122 |
| EV/EBITDA | -0.39 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 47.10% |
| Shares Outstanding | $234.70M |
| Float | $211.16M |
| % Insiders | 4.16% |
| % Institutions | 72.82% |
Analyst Ratings
Consensus ($3.69 target)
1
Strong Buy2
Buy5
Hold1
Strong SellData last updated: 4/8/2026